Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Oxycodone helps lessen pain caused by cancer and may improve quality of life. It
is not yet known whether oxycodone works better and is more cost effective than standard
therapy in treating patients with cancer pain.
PURPOSE: This randomized phase IV trial is studying oxycodone to see how well it works
compared with standard pain therapy in treating patients with cancer pain and if it is more
cost effective than standard pain therapy.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospitals Bristol and Weston NHS Foundation Trust University Hospitals Bristol NHS Foundation Trust